Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | FAAH | O00519 | 2/20 | 0.39 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.39 |
| ▸ | F7 | P08709 | 1/20 | 0.38 |
| ▸ | F3 | P13726 | 1/20 | 0.38 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.33 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.33 |
| ▸ | GMNN | O75496 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11250699 | 0.82 | TSHR (0.41) | TSHRALDH1A1FAAHTRPV1F7 | |
| SCHEMBL11250695 | 0.82 | TSHR (0.41) | TSHRALDH1A1FAAHTRPV1F7 | |
| SCHEMBL386780 | 0.80 | — | — | |
| SCHEMBL12361650 | 0.80 | — | — | |
| SCHEMBL13660445 | 0.78 | — | — | |
| SCHEMBL23566850 | 0.77 | FAAH (0.55) | TSHRALDH1A1FAAHTRPV1F7 | |
| SCHEMBL93117 | 0.77 | FAAH (0.55) | TSHRALDH1A1FAAHTRPV1F7 | |
| SCHEMBL93116 | 0.77 | FAAH (0.55) | TSHRALDH1A1FAAHTRPV1F7 | |
| SCHEMBL17262056 | 0.77 | FAAH (0.55) | TSHRALDH1A1FAAHTRPV1F7 | |
| SCHEMBL9133782 | 0.77 | FAAH (0.55) | TSHRALDH1A1FAAHTRPV1F7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 159 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12421475-B2 | High performing, high impact bloom accord with a top, medium, and base note mixture | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2025-09-23 | — | — | US | disclosed |
| EP-4615958-A1 | CELL COMPOSITIONS | Givaudan SA (CH) | 2025-09-17 | — | — | EP | disclosed |
| US-12357547-B2 | Compositions containing microcapsules | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2025-07-15 | — | — | US | disclosed |
| US-12274771-B2 | Polyurea capsule compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2025-04-15 | — | — | US | disclosed |
| CN-119233765-A | Biodegradable microcapsule and preparation method thereof | 赞普拉有限公司 | 2024-12-31 | — | — | CN | disclosed |
| WO-2024100137-A1 | CELL COMPOSITIONS | GIVAUDAN SA (CH) | 2024-05-16 | — | — | WO | disclosed |
| US-11950607-B2 | Myceliated vegetable protein and food compositions comprising same | Mycotechnology, Inc. (US) | 2024-04-09 | — | — | US | disclosed |
| US-20230363427-A1 | PREPARATION OF A SOLID FLAVOUR COMPOSITION, A COMPOSITION, FOOD COMPRISING THE COMPOSITION AND A FLAVOUR IMPARTING METHOD | GIVAUDAN SA (CH) | 2023-11-16 | — | — | US | disclosed |
| US-20230337707-A1 | MICROENCAPSULATION WITH PLANT PROTEIN | INT FLAVORS & FRAGRANCES INC (US) | 2023-10-26 | — | — | US | disclosed |
| US-20230172820-A1 | Compositions Containing Microcapsules | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2023-06-08 | — | — | US | disclosed |
| US-4609754-A | UNSATURATED ALCOHOL AND KETO ESTER | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1986-09-02 | — | — | US | disclosed |
| US-4599237-A | VEGETABLE, RASPBERRY, CABBAGE | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1986-07-08 | — | — | US | disclosed |
| US-4565707-A | TASTE, ODOR ENHANCERS FOR FOODS, MEDICINES | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1986-01-21 | — | — | US | disclosed |
| US-4560499-A | Isosolanone and solanone intermediates and organoleptic uses | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1985-12-24 | — | — | US | disclosed |
| US-4552770-A | FOODS, CHEWING GUM | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1985-11-12 | — | — | US | disclosed |
| US-4521613-A | ORGANOLEPTICS | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1985-06-04 | — | — | US | disclosed |
| US-4476147-A | Flavoring of alliaceous-flavored foodstuffs | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1984-10-09 | — | — | US | disclosed |
| US-4433695-A | Process for the production of isosolanone and solanone, intermediates useful in said process and organoleptic uses of said intermediates | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1984-02-28 | — | — | US | disclosed |
| EP-0021481-B1 | Artifically flavoured edible oils or fats | THE PROCTER & GAMBLE COMPANY (US) | 1983-02-16 | — | — | EP | disclosed |
| EP-0021481-A1 | Artifically flavoured edible oils or fats | THE PROCTER & GAMBLE COMPANY (US) | 1981-01-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12357547-B2 | Compositions containing microcapsules | COPE, SAAL1, AUP1 | TSHR 3290/4885ALDH1A1 4610/4885FAAH 3610/4885 |
| US-20230172820-A1 | Compositions Containing Microcapsules | COPE, SAAL1, AUP1 | TSHR 3290/4885ALDH1A1 4610/4885FAAH 3610/4885 |
| US-12274771-B2 | Polyurea capsule compositions | PUF60, UMPS, PCBP1 | TSHR 3075/4885ALDH1A1 4096/4885FAAH 4333/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.